I. Ahrens

发表

Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox

R. Welsh, K. Alhabib, I. Ahrens, 2019, Clinical cardiology.

Optimised care of elderly patients with acute coronary syndrome

H. Bueno, C. Hassager, S. Leonardi, 2018, European heart journal. Acute cardiovascular care.

Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System.

W. Vach, C. Bode, I. Ahrens, 2015, International journal of cardiology.

Asymptomatic atrial fibrillation and risk of stroke.

C. Bode, I. Ahrens, A. Zirlik, 2015, Panminerva medica.

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors

R. de Caterina, E. Grove, P. Gurbel, 2017, European heart journal. Cardiovascular pharmacotherapy.

Aortic root volume is associated with contained rupture of the aortic annulus in balloon‐expandable transcatheter aortic valve replacement

M. Langer, P. Blanke, C. Bode, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

New parenteral anticoagulants: focus on factor Xa and thrombin inhibitors.

C. Bode, I. Ahrens, 2012, Current drug discovery technologies.

Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques

A. Murphy, K. Peter, I. Ahrens, 2009, Circulation research.

Functionalized Magnetic Resonance Contrast Agent Selectively Binds to Glycoprotein IIb/IIIa on Activated Human Platelets under Flow Conditions and Is Detectable at Clinically Relevant Field Strengths

J. Hennig, C. Bode, K. Peter, 2008, Molecular imaging.

Protective Role for Toll-Like Receptor-9 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice

S. Akira, M. Sweet, K. Peter, 2014, Arteriosclerosis, thrombosis, and vascular biology.

A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists.

C. Bode, K. Peter, I. Ahrens, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Therapeutic Inhibitors of Platelet Aggregation – from Aspirin to Integrin Blockersf

C. Bode, K. Peter, I. Ahrens, 2007, Transfusion Medicine and Hemotherapy.

Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis

H. Busch, C. Bode, I. Ahrens, 2021, BMC Cardiovascular Disorders.

Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency

M. Bock, C. Bode, I. Ahrens, 2018, PloS one.

Use of GPIIb/IIIa inhibitors in cardiovascular medicine

C. Bode, K. Peter, I. Ahrens, 2003, Expert review of cardiovascular therapy.

GPVI and GPIbα Mediate Staphylococcal Superantigen-Like Protein 5 (SSL5) Induced Platelet Activation and Direct toward Glycans as Potential Inhibitors

K. Peter, I. Ahrens, G. Krippner, 2011, PloS one.

Antithrombotische Therapie nach strukturellen kardialen Interventionen

F. Neumann, M. Dörr, I. Ahrens, 2020, Der Kardiologe.

Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology

C. Bode, K. Peter, I. Ahrens, 2007, Expert Opinion on Drug Metabolism & Toxicology.

Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology.

C. Bode, K. Peter, I. Ahrens, 2007, Expert opinion on drug metabolism & toxicology.

Anticoagulation during and after acute coronary syndrome

C. Bode, I. Ahrens, A. Zirlik, 2013, Hämostaseologie.

Platelet Inhibition as a Therapeutic Approach in Intravascular Intervention

H. Bueno, I. Ahrens, 2017 .

Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry

C. Bode, I. Ahrens, D. Staudacher, 2015, PloS one.

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio

B. Gorenek, G. Boriani, L. Fauchier, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Editor’s Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association

H. Bueno, P. Sinnaeve, T. Münzel, 2017, European heart journal. Acute cardiovascular care.

Direct oral anticoagulants in acute coronary syndrome.

C. Bode, I. Ahrens, 2014, Seminars in hematology.

Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction.

M. Tewari, C. Bode, K. Peter, 2018, International journal of cardiology.

Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association

G. Lip, C. Vrints, D. Zahger, 2020, European heart journal. Acute cardiovascular care.

Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury

C. Bode, I. Ahrens, D. Duerschmied, 2020, Applied Sciences.

Inhibition of platelet activation and aggregation.

C. Bode, K. Peter, I. Ahrens, 2005, Handbook of experimental pharmacology.

The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause: aims, function, and structure: position paper of the ACVC association of the ESC, EAPCI, EHRA, ERC, EUSEM, and ESICM.

J. Nolan, X. Jouven, L. Bossaert, 2020, European heart journal. Acute cardiovascular care.

Influence of extracorporeal membrane oxygenation on serum microRNA expression

S. Grundmann, C. Bode, I. Ahrens, 2019, The Journal of international medical research.

Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease.

C. Bode, C. Mueller, I. Ahrens, 2019, International journal of cardiology.

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease.

C. Bode, I. Ahrens, M. Follo, 2018, Journal of visualized experiments : JoVE.

Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients

C. Bode, K. Peter, I. Ahrens, 2017, Acta Pharmacologica Sinica.

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells

C. Bode, K. Peter, I. Ahrens, 2021, Scientific Reports.

Serotonin Antagonism Improves Platelet Inhibition in Clopidogrel Low-Responders after Coronary Stent Placement: An In Vitro Pilot Study

C. Bode, I. Ahrens, M. Moser, 2012, PloS one.

Targeting Ligand-Induced Binding Sites on GPIIb/IIIa via Single-Chain Antibody Allows Effective Anticoagulation Without Bleeding Time Prolongation

C. Bode, K. Peter, I. Ahrens, 2007, Arteriosclerosis, thrombosis, and vascular biology.

HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi

M. Sweet, K. Peter, I. Ahrens, 2015, Thrombosis and Haemostasis.

Conformation-Specific Blockade of the Integrin GPIIb/IIIa: A Novel Antiplatelet Strategy That Selectively Targets Activated Platelets

C. Bode, K. Peter, D. Fitzgerald, 2006, Circulation research.

Distinct roles of ligand affinity and cytoskeletal anchorage in αIIbβ3 (GP IIb/IIIa)-mediated cell aggregation and adhesion

C. Bode, K. Peter, I. Ahrens, 2004 .

Novel Single-Chain Antibody-Targeted Microbubbles for Molecular Ultrasound Imaging of Thrombosis: Validation of a Unique Noninvasive Method for Rapid and Sensitive Detection of Thrombi and Monitoring of Success or Failure of Thrombolysis in Mice

M. Olschewski, K. Peter, I. Ahrens, 2012, Circulation.

2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group.

H. Thiele, C. Vrints, H. Bueno, 2021, European heart journal. Acute cardiovascular care.

Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.

G. Lip, C. Bode, K. Peter, 2012, Discovery medicine.

Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury

K. Peter, J. Haigh, Xiao-Ming Gao, 2017, Theranostics.

Therapeutic integrin inhibition: Allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies

K. Peter, I. Ahrens, 2008, Thrombosis and Haemostasis.

The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction

C. Bode, K. Peter, C. Gibson, 2019, European heart journal. Acute cardiovascular care.

[Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation].

H. Lipp, T. Helms, H. Riess, 2017, Deutsche medizinische Wochenschrift.

Platelet‐neutrophil complex formation—a detailed in vitro analysis of murine and human blood samples

C. Bode, I. Ahrens, D. Duerschmied, 2016, Journal of leukocyte biology.

Technical Advance: Platelet-neutrophil complex formation—a detailed in vitro analysis of murine and human blood samples

C. Bode, I. Ahrens, D. Duerschmied, 2015 .

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.

D. Atar, C. Held, B. Lewis, 2022, European heart journal.

Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis

H. Busch, C. Bode, I. Ahrens, 2021, BMC Cardiovascular Disorders.

Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis

T. Münzel, I. Ahrens, S. Konstantinides, 2022, Clinical Research in Cardiology.

Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC.

J. Stasch, C. Bode, K. Peter, 2011, Atherosclerosis.

Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment

C. Bode, I. Ahrens, D. Duerschmied, 2021, BMC Infectious Diseases.

Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.

C. Bode, K. Peter, I. Ahrens, 2017, International journal of cardiology.

Epidemiology, monitoring, and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section.

C. Hassager, X. Rosselló, I. Ahrens, 2022, European heart journal. Acute cardiovascular care.

Adhesion of Monocytes to Medical Steel as Used for Vascular Stents is Mediated by the Integrin Receptor Mac-1 (CD11b/CD18; α M β 2 ) and Can be Inhibited by Semiconductor Coating

M. Olschewski, C. Bode, K. Peter, 2003, Cell communication & adhesion.

Oral anticoagulation with edoxaban.

C. Bode, I. Ahrens, 2012, Hamostaseologie.

Novel antiplatelet therapies following percutaneous coronary interventions.

C. Bode, I. Ahrens, 2009, Current opinion in investigational drugs.

Bleeding Complications Drive In-Hospital Mortality of Patients with Atrial Fibrillation after Transcatheter Aortic Valve Replacement

C. Bode, I. Ahrens, K. Kaier, 2020, Thrombosis and Haemostasis.

Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.

G. Lip, C. Bode, K. Peter, 2012, Discovery medicine.

Targeted temperature management: a transatlantic view.

I. Ahrens, J. Pöss, 2022, European heart journal. Acute cardiovascular care.

Targeted temperature management: a transatlantic view An Why did the TTM2 trial change your daily practice of targeted temperature management in survivors of out of hospital cardiac arrest?

I. Ahrens, J. Pöss, 2022 .

Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces

C. Bode, I. Ahrens, C. Hehrlein, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Towards Effective and Safe Thrombolysis and Thromboprophylaxis: Preclinical Testing of a Novel Antibody-Targeted Recombinant Plasminogen Activator Directed Against Activated Platelets

K. Peter, R. Medcalf, I. Ahrens, 2014, Circulation research.

Successful In Vitro Expansion and Differentiation of Cord Blood Derived CD34+ Cells into Early Endothelial Progenitor Cells Reveals Highly Differential Gene Expression

I. Haviv, C. Bode, K. Peter, 2011, PloS one.

Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany

I. Ahrens, B. Monga, E. Sidelnikov, 2021, Advances in Therapy.

A Mechanistic Model for Paradoxical Platelet Activation by Ligand-Mimetic &agr;IIb&bgr;3 (GPIIb/IIIa) Antagonists

Meike Schwarz, Ingo Ahrens, Karlheinz Peter, 2007 .

Immune functions of platelets

C. Bode, I. Ahrens, D. Duerschmied, 2014, Thrombosis and Haemostasis.

High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice

K. Peter, M. Nishibori, I. Ahrens, 2011, Arteriosclerosis, thrombosis, and vascular biology.

New oral anticoagulant drugs in cardiovascular disease

K. Peter, I. Ahrens, G. Lip, 2010, Thrombosis and Haemostasis.

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

K. Peter, I. Ahrens, G. Lip, 2011, Thrombosis and Haemostasis.

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations

C. Bode, I. Ahrens, 2014, Journal of blood medicine.

Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACS

C. Bode, K. Peter, I. Ahrens, 2019, PloS one.

CD40 Ligand Mediates Inflammation Independently of CD40 by Interaction With Mac-1

P. Libby, C. Bode, K. Peter, 2007, Circulation.

Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation

C. Normann, K. Ley, C. Bode, 2019, Circulation.

Selenium supplementation induces metalloproteinase‐dependent L‐selectin shedding from monocytes

C. Bode, K. Peter, I. Ahrens, 2008, Journal of leukocyte biology.

Dual pathway therapy in acute coronary syndrome

C. Bode, I. Ahrens, A. Zirlik, 2016, Journal of Thrombosis and Thrombolysis.

Extracellular HtrA2 Induces Apoptosis in Human Umbilical Vein Endothelial Cells

C. Bode, K. Peter, I. Ahrens, 2019, International journal of molecular sciences.

Genetic transfer of fusion proteins effectively inhibits VCAM-1-mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage

C. Bode, K. Peter, I. Ahrens, 2008, Journal of cellular and molecular medicine.

[Antiplatelet therapy and anticoagulation in patients with coronary heart disease].

I. Ahrens, J-P Liedtke, 2021, Deutsche medizinische Wochenschrift.

Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome

Samuel Robinson, Ingo Ahrens, Christoph Hehrlein, 2018, Acta Pharmacologica Sinica.

Current status and needs for changes in critical care training: the voice of the young cardiologists.

P. Kirchhof, I. Ahrens, E. Bonnefoy, 2021, European heart journal. Acute cardiovascular care.

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation

C. Bode, I. Ahrens, T. Wengenmayer, 2016, PloS one.

Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes

R. Becker, S. Zelenkofske, C. Bode, 2019, European heart journal. Acute cardiovascular care.

Towards Effective and Safe Thrombolysis and ThromboprophylaxisNovelty and Significance

K. Peter, R. Medcalf, I. Ahrens, 2014 .

Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells

I. Haviv, C. Bode, K. Peter, 2011, Basic Research in Cardiology.

De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis

M. Valgimigli, J. T. ten Berg, D. Sibbing, 2023, Nature Reviews Cardiology.

Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury.

C. Bode, K. Peter, I. Ahrens, 2017, International journal of cardiology.

Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

G. Filippatos, A. Mebazaa, L. Lund, 2023, European journal of heart failure.

Humanizing mouse thrombi

K. Peter, I. Ahrens, 2008, Nature Biotechnology.

The Benefits of Rivaroxaban (Xarelto®) Across Multiple Indications and the Relevance to Cardiologists

C. Bode, I. Ahrens, 2013, EMJ Cardiology.

Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients

C. Bode, K. Peter, I. Ahrens, 2018, Acta Pharmacologica Sinica.

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial

P. Verhamme, I. Ahrens, H. Darius, 2019, Thrombosis and Haemostasis.

[Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation].

H. Lipp, T. Helms, T. Helms, 2017, Deutsche medizinische Wochenschrift.

Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease.

C. Bode, I. Ahrens, R. Twerenbold, 2019, International journal of cardiology.

Optimised care of elderly patients with acute coronary syndrome

H. Bueno, C. Hassager, S. Leonardi, 2018, European heart journal. Acute cardiovascular care.

M. Olschewski, K. Peter, I. Ahrens, 2012, Circulation.